Jonathan Stewart is a Psychiatry physician. ClinicalTrials.gov lists 10 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
127 Berkeley Pl
Brooklyn, NY 112173603
Telephone
718-783-3218Registry record last updated 7 Jan 2008.
Clinical trials
- Add-on to Cognitive, Event-Related Potentials (ERP) and Electroencephalogram (EEG) Asymmetry in Affective Disorders
Sponsor: New York State Psychiatric Institute
- Are Bright Lights and Regulated Sleep Effective Treatment for Depression?
Sponsor: New York State Psychiatric Institute
- Out-patient Wake Therapy, Light Therapy and Sleep Phase Advance for Depression
Sponsor: New York State Psychiatric Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Aminoketone37.1%Bupropion Xl100%Part D<11 patientsCentral Nervous System Stimulant36%Dextroamphetamine Sulfate50%Methylphenidate Er (La)50%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1993–2010 per NIH RePORTER. The latest:
- Combining Antidepressants to Hasten Remission from Depression
New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
FY2010$206,842R01MH076961 - Combining Antidepressants to Hasten Remission from Depression
New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
FY2009$435,643R01MH076961 - Combining Antidepressants to Hasten Remission from Depression
New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
FY2008$342,245R01MH076961
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”